The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.

Subscribe

Title Date published
Nouscom bets on dual vaccine strategy to outsmart cancer 2025-07-25
Is this a revolution in Alzheimer's? 2025-06-12
Why Boehringer and GSK are betting on Ochre 2025-05-23
ICON's AI strategy: faster, smarter trials 2025-05-08
How real-time data could transform clinical trials 2025-03-11
Japanese pharma in the UK 2025-02-14
How can we use AI to program antibodies? 2024-11-14
Breakthroughs in MASH, with 89bio CEO 2024-06-25
How to develop cancer drugs faster, with Ellipses Pharma 2024-01-17
CRO sector surges in bio revolution 2023-10-24
Lilly looks to lead in Alzheimer's 2023-07-17
AAIC preview with Eisai deputy CCO Michael Irizarry 2023-07-06
A new way to innovate, from Flagship Pioneering 2023-04-20
Will radical new EU regs hobble industry? 2023-03-31
Galapagos update—with CEO Paul Stoffels 2023-02-02
US midterms and beyond: the outlook for pharma 2022-11-28
Focus on rare liver diseases, with Albireo CEO Ron Cooper 2022-10-19
Inflation Reduction Act: quick take 2022-08-16
EQRx plots radical disruption on pricing 2022-07-22
Can AI find new drugs for metabolic diseases? 2022-07-01
12

Comments about The Pharma Letter Podcast

comments powered by Disqus
Advertisment: